Objective: To investigate clinical significance in the application of 23-valent pneumococcus polysaccharide vaccine in bronchiectatic patients. 目的:探讨23价肺炎球菌多糖疫苗在支气管扩张患者的临床意义。
Conclusion: 23-valent pneumococcus polysaccharide vaccine could effectively reduce recurrent rate of pulmonary infection in bronchiectatic patients. Therefore, it might be an effective adjuvant for the treatment of bronchiectasis, which is worth extending its clinical application. 结论:23价肺炎球菌多糖疫苗能有效地减少支气管扩张患者肺部感染复发率,是临床佐治支气管扩张患者的一个有效方法,值得临床推广。
Clinical observation on the application of 23-valent pneumococcus polysaccharide vaccine in bronchiectatic patients 支气管扩张病例应用23价肺炎球菌多糖疫苗的临床观察